Insulin glulisine clinical trials
Also written Apidra.
Its developmentBy 4 companies, company by company42 company-led studies, furthest phase 4: when each phase was reached, its deals, target and what is ahead.How each study uses insulin glulisine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 16 Apr 2004 · APIDRA SOLOSTAR · BLA 021629 (FDA, Drugs@FDA)
- European Union
- 27 Sept 2004 · Apidra · EMEA/H/C/000557 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
65 studies that test it; most in 2004 (10)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 10 |
| 2005 | 7 |
| 2006 | 3 |
| 2007 | 9 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 7 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 43 · Other 22
Sanofi (38) · Medical University of Warsaw (5) · Emory University (2) · HealthPartners Institute (2) · ikfe-CRO GmbH (2) · Geropharm (1) · Kinderkrankenhaus auf der Bult (1) · Spectrum Health Hospitals (1)
Often tested with
Tested in the same studies.
Insulin Glargine (25) · Insulin Aspart (10) · Insulin Lispro (8) · Insulin (3) · Repaglinide (1) · Acarbose (1) · Insulin degludec (1) · Metformin (1)
Related medicines
As reviewed, each with the page that says it.
- One of Hypoglycemic Agents source
Studies
Open first, then newest update. How each study uses insulin glulisine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 65
- The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.CompletedPhase 4Medical University of WarsawNCT04124302Written as Insulin GlulisineHow we know
- Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus PatientsCompletedPhase 3GeropharmNCT07070752Written as GP40321How we know
- Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)CompletedPhase 4Kinderkrankenhaus auf der BultNCT02914886Written as ApidraHow we know
- Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 DiabetesTerminatedPhase 4Centre Hospitalier Universitaire DijonNCT02048189Written as APIDRAHow we know
- Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index MealCompletedPhase 4Medical University of WarsawNCT04019821Written as Insulin GlulisineHow we know
- The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal ChildrenCompletedPhase 4Spectrum Health HospitalsNCT00913497Written as insulin glulisineHow we know
- A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes MellitusCompletedPhase 1SanofiNCT02910518Written as Insulin glulisine (U300)How we know
- Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyCompletedPhase 4SanofiNCT03359837Written as Insulin GlulisineHow we know
- Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)CompletedPhase 4Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludNCT03328845Written as ApidraHow we know
- Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's DiseaseTerminatedPhase 2HealthPartners InstituteNCT02503501Written as Insulin glulisineHow we know
- Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DMCompletedNot applicableCairo UniversityNCT01855243Written as glulisineHow we know
- Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) PatientsCompletedPhase 3Emory UniversityNCT01792830Written as GlulisineHow we know
- Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational DiabetesCompletedPhase 2Sansum Diabetes Research InstituteNCT01662921Written as Insulin glulisineHow we know
- Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical WardsCompletedPhase 4HaEmek Medical Center, IsraelNCT01594060Written as Insulin glulisine, Insulin glargineHow we know
- Normal Versus Dual Wave Insulin Bolus for High-protein FoodCompletedPhase 4Medical University of WarsawNCT02276859Written as insulin glulisineHow we know
- Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 DiabetesCompletedPhase 1Novo Nordisk A/SNCT00824668Written as insulin glulisineHow we know
- Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.Status unknownPhase 4Medical University of WarsawNCT02685449Written as Insulin glulisineHow we know
- Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a DayCompletedPhase 4SanofiNCT01234597Written as INSULIN GLULISINE (HMR1964)How we know
- Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and AdolescentsCompletedPhase 3SanofiNCT00115570Written as Insulin glulisineHow we know
- Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.CompletedPhase 2HealthPartners InstituteNCT01436045Written as Insulin glulisineHow we know
See all 65 studies that test insulin glulisine →
Given beside what is tested · 12 — insulin glulisine is usual care or a partner of the new treatment
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)CompletedPhase 3SanofiNCT03529123Written as Insulin Glulisine (HMR1964)How we know
- Glargine U300 Hospital TrialCompletedPhase 4Emory UniversityNCT03013985Written as Glulisine InsulinHow we know
- Investigation of the Safety of Intranasal Glulisine in Down SyndromeCompletedPhase 1HealthPartners InstituteNCT02432716Written as Insulin glulisineHow we know
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes MellitusCompletedPhase 2Halozyme TherapeuticsNCT01194245Written as Insulin glulisineHow we know
- CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)CompletedPhase 4Halozyme TherapeuticsNCT01848990Written as Insulin glulisineHow we know
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes MellitusCompletedPhase 2Halozyme TherapeuticsNCT01194258Written as Insulin glulisineHow we know
- A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs AloneCompletedPhase 1Halozyme TherapeuticsNCT00979875Written as Insulin glulisineHow we know
- Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.CompletedPhase 4SanofiNCT01122979Written as INSULIN GLULISINEHow we know
- Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative StudyCompletedPhase 4SanofiNCT01121835Written as INSULIN GLULISINEHow we know
- Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral NutritionTerminatedPhase 4SanofiNCT01081938Written as INSULIN GLULISINEHow we know
- Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory ControlTerminatedPhase 4SanofiNCT00283049Written as Insulin GlulisineHow we know
- Opposing Step-by-step Insulin Reinforcement to Intensified StrategyCompletedPhase 3SanofiNCT00174642Written as Insulin GlulisineHow we know
As the comparator · 1 — what is tested is compared with insulin glulisine
Codes
What other systems call insulin glulisine · ClinicalTrials.gg INT004581
- MeSH (NLM) C479079insulin glulisineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7XIY785AZDINSULIN GLULISINEConfirmed FDA, NLM, Wikidata
- RxNorm 400008Confirmed FDA, Wikidata
- Wikidata Q6042242insulin glulisineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65921Insulin GlulisineConfirmed FDA, Wikidata
- DrugBank DB01309One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C479079 | insulin glulisine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7XIY785AZD | INSULIN GLULISINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 400008 | — | Confirmed FDA, Wikidata |
| Wikidata | Q6042242 | insulin glulisine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65921 | Insulin Glulisine | Confirmed FDA, Wikidata |
| DrugBank | DB01309 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.